Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 8 Anxiety Disorders 6 Neoplasms 4 Depression 4 Lymphoma 2 Stress, Psychological 1 Smoking Cessation 1 Smoking 1 Skin Neoplasms 1 Parasomnias 1 Pain, Postoperative 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Motor Activity 1 Melanoma 1 Hot Flashes 1 Hematopoietic and Lymphoid System Neoplasm 1 Glioma 1 Colonic Neoplasms 1 Chronic Pain 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1

Interventions

Fluorouracil 128 Leucovorin 120 Oxaliplatin 101 Irinotecan 89 Bevacizumab 55 Cetuximab 44 Capecitabine 40 Folfox protocol 29 Panitumumab 22 Colonoscopy 17 Chemotherapy, Adjuvant 16 Floxuridine 15 Early Intervention, Educational 15 Erlotinib Hydrochloride 13 Surveys and Questionnaires 11 IFL protocol 11 Counseling 11 Celecoxib 11 Immunohistochemistry 10 Gemcitabine 10 Psychiatric Rehabilitation 9 Methods 8 Magnetic Resonance Spectroscopy 8 Gene Expression Profiling 8 Exercise 8 Dexamethasone 8 sargramostim 7 Sorafenib 7 Radiotherapy 7 Nivolumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Colonic Neoplasms × Mindfulness × Clear all

NCT06323421 2025-11-21

MindCRC

University of Illinois at Chicago

Phase NA Completed

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡